-
By Kshitij Raizada, MS Ophthalmology
Dr. Raizaday Eye Centre
Co-author(s): ASRS - Uploaded on Aug 25, 2020.
- Last modified by Joshua Friedman on Nov 4, 2022.
- Rating
- Appears in
- Miscellaneous
- Condition/keywords
- polypoidal choroidal vasculopathy (PCV), peripheral exudative hemorrhagic chorioretinopathy (PEHCR), indocyanine green (ICG) angiography, video
- Description
- A 36-year-old female presented to with complaints of diminution of vision in LE for 3 months. Her BCVA in the RE was 6/6 and CF@1m in the LE. She was a K/C/O polypoidal choroidal vasculopathy (PCV) in the RE and had a history of receiving 2 doses of intravitreal Aflibercept (Eylea) in the RE. On her visit, she had dense Vitreous hemorrhage in the LE. 25G pars plana vitrectomy + intravitreal Aflibercept was planned for her. On clearing the vitreous hemorrhage, the patient was found to have Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR). An on-table diagnosis of "PCV causing PEHCR" was made. Endolaser was done to sites suspicious to have underlying polyps. The patient's vision improved to 6/18 in the LE after one week of surgery. One month post-surgery, her BCVA in the LE had improved to 6/9. ICG angiography was done which revealed non-leaking BVN(branching vascular network) and no polyps. The patient has been doing well and has been kept under observation.